Nuvaira
Company

Last deal

$52.88K

Amount

Venture - Series Unknown

Stage

09.05.2024

Date

3

all rounds

$194.04M

Total amount

date founded

Financing round

General

About Company
Nuvaira is a company that develops devices for treating lung diseases, offering an alternative COPD treatment option.

Industry

Sector :

Subsector :

Also Known As

Innovative Pulmonary Solutions, Holaira

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

With a focus on improving outcomes for patients with obstructive lung diseases, Nuvaira is developing a novel catheter-based system to treat overactive airway nerves. This innovative device has the potential to enhance lung function, exercise capacity, and quality of life for individuals with chronic obstructive pulmonary disease. Founded in 2008, Nuvaira aims to address the clinical needs of more than 65 million people worldwide suffering from obstructive lung disease. The company is headquartered in Minneapolis, Minnesota, and holds over 75 patents issued and pending globally. While the dNerva® Lung Denervation System is CE Mark approved, it is currently under clinical investigation and not yet available for commercial use in the USA.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
Emphasys Medical

Emphasys Medical

Ephrasys Medical develops minimally invasive therapies for the treatment of chronic obstructive pulmonary diseases.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical, Medical Device

Location

Redwood City, CA, USA

total rounds

3

total raised

$67.7M
Magenta Medical

Magenta Medical

Magenta Medical Ltd. develops novel device solutions for the treatment of acute and chronic heart failure.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Kadima, Kadima Zoran, Israel

total rounds

4

total raised

$74M
Soundbite Medical Solutions

Soundbite Medical Solutions

Soundbite is a medical device company developing products for vessel preparation and treatment.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Dorval, QC, Canada

total rounds

6

total raised

$38.5M
InterCure

InterCure

InterCure developed a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Therapeutics, Medical Device

Location

Ra'anana, Israel

total rounds

6

total raised

$41.9M

count Of Investments

1

Financials

Funding Rounds
11
3

Number of Funding Rounds

$194.04M

Money Raised

Their latest funding was raised on 09.05.2024. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
09.05.2024
$52.88K
30.11.2023
$15.12M
15.01.2021
$3.92M
Co-Investors
Investors
10
3

Number of lead investors

10

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series A, Series B, Series C, Series D, Series E
Split Rock Partners

Split Rock Partners

Split Rock Partners invests in early-stage healthcare, software, and Internet services companies in the Midwest and West Coast.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Minneapolis, MN, USA

count Of Investments

87

count Of Exists

37
David Stassen

David Stassen

Dave Stassen is a founding Managing Director of Split Rock Partners and a member of the firm's healthcare investment team. While his investing purview spans the country, Dave focuses particularly on the strong medical technology industry in Minnesota. Prior to founding Split Rock Partners, Dave was a General Partner with St. Paul Venture Capital's healthcare team. He rejoined St. Paul Venture Capital in 2000, nine years after he left the firm to lead Spine-Tech, an emerging growth company specializing in development and marketing of revolutionary spinal implant products. Dave led Spine-Tech from its formation in 1991 through growth in revenue to over $100 million. The company was acquired in January 1998 for over $600 million. In acknowledgement of this success, Stassen was named the 1998 Ernst & Young National Entrepreneur of the Year. From 1980 to 1990, Dave was a venture capitalist with North Star Ventures, an early-stage venture capital firm based in Minneapolis. Dave began his business career with IBM Corporation. He holds a bachelor's degree in quantitative methods and an MBA from the University of St. Thomas in St. Paul, Minnesota.

current job

Split Rock Partners
Split Rock Partners
Windham Venture Partners

Windham Venture Partners

Windham is a venture capital firm based in New York City that invests in healthcare, with a focus on medical technology and digital health.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

New York, NY, USA

count Of Investments

44

count Of Exists

5
Richard King Mellon Foundation

Richard King Mellon Foundation

Richard King Mellon Foundation invests in Southwestern PA's future and America's environmental heritage.

Sector

Construction and Materials

Subsector

Construction

Location

Pittsburgh, PA, USA

count Of Investments

32

count Of Exists

1

People

Founders
2
Martin L. Mayse
Martin L. Mayse

Martin L. Mayse

Martin L. Mayse is the Founder and Chief Executive Officer at Pleural Dynamics, Inc.. Attended Yale University School of Medicine.

current job

Pleural Dynamics Inc

organization founded

2

Martin L. Mayse

Steve Dimmer
Steve Dimmer

Steve Dimmer

current job

CurvaFix
CurvaFix

organization founded

2

Steve Dimmer

Employee Profiles
14

Karen Peterson

Vice President Clinical, Regulatory & Quality

Tom Griffin

Chief Financial Officer

Steve Thomas

Vice president patient access

Lisa Rogan

SVP Global Market Development

Philip Johnson

Senior director, science and technology

Danielle Forstner

Clinical data manager at holaira

Dennis W. Wahr

Dennis W. Wahr

Board of Directors, President & CEO

Activity

Recent News
0